|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.63 USD | -3.31% |
|
-4.71% | -35.38% |
| 20/05 | Procaps Group Gets Nasdaq Noncompliance Notice for Late Filing of Annual Report | MT |
| 01/05 | Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023 | CI |
Procaps Group announced the appointment of Melissa Angelini as Investor Relations Director, effective February 1, 2022. Melissa Angelini is a seasoned executive with over 15 years of experience in capital markets and investor relations with healthcare and pharmaceutical companies. She has extensive experience with clients in Latin American countries including Brazil, Mexico, Argentina, Chile, Colombia and Peru.
Previously she was Innovation & Investor Relations Officer at Blau Farmacêutica.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.38% | 30Cr | |
| +45.82% | 77TCr | |
| +40.95% | 63TCr | |
| -6.16% | 35TCr | |
| +19.86% | 33TCr | |
| +9.32% | 30TCr | |
| +18.45% | 25TCr | |
| -0.78% | 22TCr | |
| +11.88% | 22TCr | |
| +5.90% | 16TCr |
PROCAPS GROUP S.A. 
